Hepatitis C research in B.C. given $5M boost

Study will look for ways to reduce new infections in the province

A new study looking at ways to reduce the incidence of hepatitis C infections across the province will be launched following funding of $5 million from the B.C. government.

The study, which will be led by Dr. Julio Montaner, director of the B.C. Centre for Excellence in HIV/AIDS (BCCFE), was announced Thursday morning by Health Minister Terry Lake.

“This initiative offers a unique opportunity to potentially curb the rapidly rising toll of hepatitis C in North America,” Montaner said.

A collaboration between the BCCFE, B.C. Centre for Disease Control, Vancouver Coastal Health, St. Paul’s Hospital Foundation and University of British Columbia, the study will focus on patients in Vancouver who have been successfully cured of hepatitis C, but are identified as at high risk of re-infection.

By evaluating treatment options, harm reduction and support services currently offered through Vancouver Coastal Health, the team hopes to identify the next steps in improving outcomes for patients.

Hepatitis C currently affects an estimated 50,000 to 60,000 British Columbians and can be life-threatening.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)